EP2979692A1 — Dosage form comprising a pressure sensitive solid form of an active pharmaceutical ingredient
Assigned to Sandoz AG · Expires 2016-02-03 · 10y expired
What this patent protects
The present invention concerns a dosage form comprising a pressure sensitive solid form of an active pharmaceutical ingredient, a first disintegrant having elastic properties, a second disintegrant and optionally a pharmaceutical excipient.
USPTO Abstract
The present invention concerns a dosage form comprising a pressure sensitive solid form of an active pharmaceutical ingredient, a first disintegrant having elastic properties, a second disintegrant and optionally a pharmaceutical excipient.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.